Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
No malformations or embryofetal toxicity were observed in fetuses from pregnant monkeys administered ixekizumab weekly by subcutaneous injection during organogenesis to near parturition at doses up to 19 times the MRHD (on a mg/kg basis of 50 mg/kg/week)
These patients may also respond better to traditional immunosuppressive treatments, further supporting the connection between metabolic health and autoimmune inflammation
The result is lower calorie intake and support for meaningful weight loss, alongside other potential health benefits
Skin collagen, hydration, elasticity, wrinkles, and scalp and hair parameters improved by 12 weeks of treatment over baseline values and when compared with placebo-control levels
US$ 22.46
US$ 22.03
US$ 25.83
US$ 26.57
US$ 21.18
